Lankenau Medical Center gains statewide recognition for preventing hospital infections
Wynnewood, PA — Lankenau Medical Center has received statewide recognition for its outstanding performance in preventing hospital infections.
The honors come from the Hospital and Healthsystem Association of Pennsylvania (HAP) through its 2023 Excellence in Patient Safety Recognition program. The organization is citing top-performing Pennsylvania hospitals that have demonstrated low rates of health care-associated infections.
“Hospital infections can have serious consequences, and our teams have an aim of zero harm,” said Katie Galbraith, MBA, FACHE, president of Lankenau Medical Center. “Preventing infection involves everyone, including physicians, nurses, the environmental services team, and so many others. They have earned this recognition and I couldn’t be prouder.”
HAP is recognizing 29 hospitals this year based on their performance during 2022. HAP identifies top-performing hospitals using data from the Centers for Disease Control and Prevention’s National Healthcare Safety Network. To be recognized, hospitals must perform better than the mean standardized infection ratio in three key measures: central line-associated bloodstream infections, catheter-associated urinary tract infections and Clostridioides difficile infections.
“HAP is proud to recognize the hospital teams with exemplary results from their efforts to continuously improve the quality and safety of patient care,” HAP President and CEO Nicole Stallings said. “This year, more hospitals met the criteria to be recognized than any other year since this program began. This speaks to the Pennsylvania hospital community’s strong commitment to patient safety.”
For more details, visit the HAP website.
About Lankenau Medical Center
Lankenau Medical Center, part of Main Line Health, has been devoted to the health and well-being of the community since 1860, with a founding mission to serve all those in need. Our continued dedication to service, compassionate patient care and superior clinical programs makes Lankenau a preferred destination for care by people throughout the Philadelphia region and beyond. Lankenau offers primary care, disease prevention and specialized medical and surgical management of all diseases and disorders, as well as access to clinical trials. As a 371-bed teaching and research institution, Lankenau is committed to maintaining high-level expertise across all clinical areas and is consistently recognized for providing outstanding care across major specialties including heart and vascular care, cancer care, obstetrics and gynecology, orthopaedics, gastroenterology, pulmonology, neurosurgery, nephrology and urology. Lankenau is ranked as one of the top three hospitals in the region and top seven in the state by U.S. News & World Report 2023-24. It is rated a high performer in the Centers for Medicare and Medicaid Services' Overall Hospital Quality Star Rating.